Repository logo
 
Publication

Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019

2019Journal article Open access
Simple item page
dc.contributor.authorPimentel-Nunes, P.
dc.contributor.authorLibânio, D.
dc.contributor.authorMarcos-Pinto, Ricardo
dc.contributor.authorAreia, M.
dc.contributor.authorLeja, M.
dc.contributor.authorGarrido, Mónica
dc.contributor.authorEsposito, j.
dc.contributor.authorKikuste, .
dc.contributor.authorMegraud, F.
dc.contributor.authorMatysiak-Budnik, T.
dc.contributor.authorAnnibale, B.
dc.contributor.authorDumonceau, J.
dc.contributor.authorBarros, R.
dc.contributor.authorFléjou, J.
dc.contributor.authorCarneiro, F.
dc.contributor.authorvan Hooft, J.
dc.contributor.authorKuipers, E.
dc.contributor.authorDinis-Ribeiro, M.
dc.date.accessioned2020-05-07T14:28:55Z
dc.date.available2020-05-07T14:28:55Z
dc.date.issued2019
dc.description.abstractPatients with chronic atrophic gastritis or intestinal metaplasia (IM) are at risk for gastric adenocarcinoma. This underscores the importance of diagnosis and risk stratification for these patients. High definition endoscopy with chromoendoscopy (CE) is better than high definition white-light endoscopy alone for this purpose. Virtual CE can guide biopsies for staging atrophic and metaplastic changes and can target neoplastic lesions. Biopsies should be taken from at least two topographic sites (antrum and corpus) and labelled in two separate vials. For patients with mild to moderate atrophy restricted to the antrum there is no evidence to recommend surveillance. In patients with IM at a single location but with a family history of gastric cancer, incomplete IM, or persistent Helicobacter pylori gastritis, endoscopic surveillance with CE and guided biopsies may be considered in 3 years. Patients with advanced stages of atrophic gastritis should be followed up with a high quality endoscopy every 3 years. In patients with dysplasia, in the absence of an endoscopically defined lesion, immediate high quality endoscopic reassessment with CE is recommended. Patients with an endoscopically visible lesion harboring low or high grade dysplasia or carcinoma should undergo staging and treatment. H. pylori eradication heals nonatrophic chronic gastritis, may lead to regression of atrophic gastritis, and reduces the risk of gastric cancer in patients with these conditions, and it is recommended. H. pylori eradication is also recommended for patients with neoplasia after endoscopic therapy. In intermediate to high risk regions, identification and surveillance of patients with precancerous gastric conditions is cost-effective.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationPimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365‐388. doi:10.1055/a-0859-1883pt_PT
dc.identifier.doi10.1055/a-0859-1883pt_PT
dc.identifier.issn0013-726X
dc.identifier.issn1438-8812
dc.identifier.urihttp://hdl.handle.net/10400.16/2375
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherThieme Publishingpt_PT
dc.relation.publisherversionhttps://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-0859-1883pt_PT
dc.titleManagement of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceGermanypt_PT
oaire.citation.endPage388pt_PT
oaire.citation.issue4pt_PT
oaire.citation.startPage365pt_PT
oaire.citation.titleEndoscopypt_PT
oaire.citation.volume51pt_PT
person.familyNameMarcos-Pinto
person.familyNameGarrido
person.givenNameRicardo
person.givenNameMónica
person.identifier.orcid0000-0001-9695-8261
person.identifier.orcid0000-0003-4538-045X
person.identifier.ridK-4612-2013
person.identifier.scopus-author-id53984773600
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication7af2c629-e150-47fc-b0e1-69831696045b
relation.isAuthorOfPublication6988c25a-eea2-4002-b740-48ed87ceb226
relation.isAuthorOfPublication.latestForDiscovery7af2c629-e150-47fc-b0e1-69831696045b

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Management of Epithelial Precancerous Conditions.pdf
Size:
1.43 MB
Format:
Adobe Portable Document Format
Download

Collections

SG - Artigos publicados em revistas indexadas na Pubmed/Medline